From pathology to intervention
RegMedLab studies how disease processes can be redirected toward repair. The lab connects beta-thalassemia biology, bone and cartilage regeneration, soft tissue healing and clinical technology platforms with a single translational goal: move robust science closer to useful health solutions.
The group is led by Dr. Nishant Chakravorty and brings together students and collaborators across biology, medicine, materials and computational tools.
How the lab works
- Mechanism-first disease biology
- RNA and genetic modulation strategies
- Biomaterials and delivery platforms
- Clinical tools and translational validation
Three problem areas, one regenerative pathway
The lab themes connect disease biology, intervention platforms and translational validation.
Beta-thalassemia
Genetic blood disorder research with emphasis on fetal hemoglobin reactivation and RNA-linked intervention strategies.
Bone and cartilage disorders
Materials and models for osteoarthritis, osteoporosis, skeletal repair and implant integration.
Soft tissue regeneration
Biomaterials, delivery systems and cell biology platforms for implant fixation and soft tissue healing.
Core capabilities that support translation
Collaborate, visit or join the lab
RegMedLab welcomes research conversations across regenerative medicine, biomaterials, molecular biology and clinical technology.